NS6180, a new KCa3.1 channel inhibitor prevents T-cell activation and inflammation in a rat model of inflammatory bowel disease. - Strøbæk, D; Brown, DT; Jenkins, DP; Chen, Y ‐ J; Coleman, N; Ando, Y; Chiu, P; Jørgensen, S; Demnitz, J; Wulff, H; Christophersen, P (British Journal of Pharmacology, 2013)